Page last updated: 2024-08-22

angiotensin ii and alacepril

angiotensin ii has been researched along with alacepril in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (37.50)	18.7374
1990's	3 (37.50)	18.2507
2000's	2 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iimura, O; Shimamoto, K	2
Ando, T; Hosoda, S; Ishida, H; Masuda, A; Nakahashi, Y; Shimamoto, K; Tanaka, S; Ura, N; Yamaji, I; Yokoyama, T	1
Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Takaori, K; Yukimura, T	1
Ito, M; Izumi, Y; Kanmatsuse, K; Soma, M	1
Endo, A; Hamada, T; Hisatome, I; Kato, M; Kato, T; Kinugawa, T; Miyakoda, H; Mori, M; Noguchi, N; Ogino, K; Omodani, H; Osaki, S; Shigemasa, C	1
Ando, H; Furugori, K; Harata, T; Mizutani, S; Murata, Y; Shibata, D	1
Fukushima Kusano, K; Hisamatsu, K; Ishihara, K; Kajiya, M; Miura, A; Miura, D; Miura, R; Morita, H; Nagase, S; Nakamura, K; Ohe, T	1

Trials

1 trial(s) available for angiotensin ii and alacepril

Article	Year
Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure. European journal of clinical pharmacology, 1998, Volume: 54, Issue:3 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteries; Atrial Natriuretic Factor; Baroreflex; Blood Pressure; Body Weight; Captopril; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Neuropeptides; Neurotransmitter Agents; Norepinephrine; Renin; Tilt-Table Test; Ventricular Function, Left	1998

Article

Year

Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.

European journal of clinical pharmacology, 1998, Volume: 54, Issue:3

Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteries; Atrial Natriuretic Factor; Baroreflex; Blood Pressure; Body Weight; Captopril; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Neuropeptides; Neurotransmitter Agents; Norepinephrine; Renin; Tilt-Table Test; Ventricular Function, Left

1998

Other Studies

7 other study(ies) available for angiotensin ii and alacepril

Article	Year
Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives. Advances in experimental medicine and biology, 1989, Volume: 247A Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bradykinin; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Diuresis; Heart Rate; Humans; Hypertension; Kallikreins; Kinins; Ramipril; Renin-Angiotensin System	1989
Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril. Clinical and experimental hypertension. Part A, Theory and practice, 1987, Volume: 9, Issue:2-3 Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Female; Humans; Hypertension, Renal; Kallikreins; Kinins; Male; Middle Aged; Renin-Angiotensin System	1987
Measurement of circulating kinins, their changes by inhibition of kininase II and their possible blood pressure lowering effect. Agents and actions. Supplements, 1987, Volume: 22 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Humans; Hypertension; Kinins; Norepinephrine; Renin	1987
Role of angiotensin II in extracellular matrix and transforming growth factor-beta 1 expression in hypertensive rats. European journal of pharmacology, 1994, Sep-15, Volume: 269, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Blotting, Northern; Captopril; Collagen; Extracellular Matrix; Gene Expression Regulation; Heart Ventricles; Hypertension; Male; Organ Size; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta	1994
Effects of long-term treatment with angiotensin-converting enzyme inhibitor on angiotensin II and prostacyclin release from mesenteric arteries in spontaneously hypertensive rats. Prostaglandins, leukotrienes, and essential fatty acids, 1995, Volume: 53, Issue:5 Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Epoprostenol; Hypertension; Isoproterenol; Male; Mesenteric Arteries; Norepinephrine; Rats; Rats, Inbred SHR; Vasodilation	1995
Dual renin-angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series. Human reproduction (Oxford, England), 2003, Volume: 18, Issue:6 Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Captopril; Chorionic Gonadotropin; Cryopreservation; Drug Therapy, Combination; Embryo Transfer; Embryo, Mammalian; Estradiol; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Renin; Renin-Angiotensin System; Risk Factors; Tetrazoles	2003
Anti-inflammatory effect of spironolactone on human peripheral blood mononuclear cells. Journal of pharmacological sciences, 2006, Volume: 101, Issue:3 Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Female; Humans; Leukocytes, Mononuclear; Male; Mineralocorticoid Receptor Antagonists; Spironolactone; Tetrazoles; Tumor Necrosis Factor-alpha	2006